SCHEMBL9119679

SCHEMBL9119679

CSc1ccc(C2=CC3(C=C2c2ccc(S(C)(=O)=O)nc2)CCC3)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.41
PTGS1 P23219 4/20 0.41
ALOX5AP P20292 1/20 0.36
PIK3CD O00329 1/20 0.34
PIP5K1C O60331 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
LRRK2 Q5S007 1/20 0.33
CTSK P43235 1/20 0.33
FAAH O00519 1/20 0.33
RORC P51449 1/20 0.32
GPR119 Q8TDV5 1/20 0.31
TSHR P16473 1/20 0.31
OPRM1 P35372 1/20 0.30
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9117970 0.98 PTGS2 (0.41) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9237630 0.95 PTGS2 (0.46) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9240652 0.87 CA12 (0.36) PTGS2PTGS1TSHR
SCHEMBL9118447 0.86 PTGS2 (0.44) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9119117 0.86 PTGS2 (0.44) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9118491 0.85 PTGS2 (0.43) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9117675 0.85 PTGS2 (0.59) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9118885 0.84 PTGS2 (0.44) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9118009 0.84 PTGS2 (0.44) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C
SCHEMBL9117653 0.83 PTGS1 (0.42) PTGS2PTGS1ALOX5APPIK3CDPIP5K1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed